◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0876

Kaisa Health Group Holdings Limited (0876) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-08-10

Kaisa Health Group Holdings Limited (0876) operates in the Medical Instruments & Supplies industry and is headquartered in Central, Hong Kong with about 825 employees. Its market capitalization is roughly HKD 215 million. In the fiscal year ended 2025-12-31, 0876 reported HKD 139M in revenue and (HKD 47M) in net income.

Kaisa Health Group Holdings Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally.

Interactive charts & full statements →

0876 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueHKD 139MHKD 185MHKD 186MHKD 192M
Gross ProfitHKD 51MHKD 82MHKD 81MHKD 83M
Operating Income (EBIT)(HKD 52M)(HKD 23M)(HKD 41M)(HKD 65M)
Net Income(HKD 47M)(HKD 46M)HKD 8M(HKD 123M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0876 Free Cash Flow History

0876 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsHKD 472MHKD 518MHKD 605MHKD 768M
Total LiabilitiesHKD 73MHKD 91MHKD 113MHKD 297M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0876 viewer.

Other Companies in Medical Instruments & Supplies

← 0875All “0-9” companies0878 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.